TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 52.8M
Gross Profit 51.5M 97.60%
Operating Income -4.6M -8.71%
Net Income -19.9M -37.67%

Balance Sheet Metrics

Total Assets 596.2M
Total Liabilities 272.4M
Shareholders Equity 323.8M
Debt to Equity 0.84

Cash Flow Metrics

Revenue & Profitability Trend

Arunjyoti Bio Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i278.8M204.3M17.4M29.7M55.1M
Cost of Goods Sold i52.2M85.2M15.0M28.8M48.1M
Gross Profit i226.6M119.1M2.4M895.4K7.0M
Gross Margin % i81.3%58.3%13.8%3.0%12.7%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-7.0M206.0K1.5M2.6M
Other Operating Expenses i86.4M37.8M451.0K819.0K1.1M
Total Operating Expenses i86.4M44.8M657.0K2.3M3.6M
Operating Income i19.7M7.7M1.7M-2.0M963.1K
Operating Margin % i7.1%3.8%9.5%-6.8%1.7%
Non-Operating Items
Interest Income i-369.0K000
Interest Expense i25.9M21.1M74.0K10.7K58.9K
Other Non-Operating Income-----
Pre-tax Income i-3.4M-13.0M1.6M760.2K922.5K
Income Tax i14.8M-9.5M410.0K197.7K239.8K
Effective Tax Rate % i0.0%0.0%26.0%26.0%26.0%
Net Income i-18.2M-3.5M1.2M562.6K682.6K
Net Margin % i-6.5%-1.7%6.7%1.9%1.2%
Key Metrics
EBITDA i52.9M28.2M1.7M770.9K981.3K
EPS (Basic) i-₹-0.03₹0.01₹0.00₹0.01
EPS (Diluted) i-₹-0.03₹0.01₹0.00₹0.01
Basic Shares Outstanding i-112990049112990049112984593112984593
Diluted Shares Outstanding i-112990049112990049112984593112984593

Income Statement Trend

Arunjyoti Bio Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i5.9M859.0K252.0K73.6K8.1M
Short-term Investments i-----
Accounts Receivable i39.6M27.3M7.8M5.4M18.4M
Inventory i26.2M29.3M8.8M0259.5K
Other Current Assets71.4M2.6M711.0K644.8K644.8K
Total Current Assets i148.0M112.8M55.3M10.9M32.1M
Non-Current Assets
Property, Plant & Equipment i433.3M45.3M00-
Goodwill i-0000
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets15.0M12.3M00-
Total Non-Current Assets i448.3M427.1M303.7M10.0M15.0M
Total Assets i596.2M539.9M359.1M21.0M47.0M
Liabilities
Current Liabilities
Accounts Payable i03.9M0167.9K13.1M
Short-term Debt i47.6M42.2M000
Current Portion of Long-term Debt-----
Other Current Liabilities5.1M4.1M1.0K239.8K239.8K
Total Current Liabilities i52.9M50.3M15.2M937.2K27.6M
Non-Current Liabilities
Long-term Debt i214.5M471.9M322.7M00
Deferred Tax Liabilities i5.0M0000
Other Non-Current Liabilities1.0K1.0K-1.0K26.6K27.3K
Total Non-Current Liabilities i219.5M471.9M322.7M26.6K27.3K
Total Liabilities i272.4M522.2M337.9M963.8K27.6M
Equity
Common Stock i186.4M20.7M20.7M20.7M20.7M
Retained Earnings i--5.4M-1.9M-3.1M-3.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i323.8M17.7M21.2M20.0M19.4M
Key Metrics
Total Debt i262.1M514.1M322.7M00
Working Capital i95.1M62.4M40.1M10.0M4.5M

Balance Sheet Composition

Arunjyoti Bio Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-3.4M-13.0M1.6M760.2K922.5K
Depreciation & Amortization i-----
Stock-Based Compensation i--00-
Working Capital Changes i-31.8M33.4M-131.8M4.4M5.0M
Operating Cash Flow i-12.1M40.9M-130.3M5.1M5.9M
Investing Activities
Capital Expenditures i-58.7M-233.3M-191.9M00
Acquisitions i--000
Investment Purchases i--000
Investment Sales i--000
Investing Cash Flow i-58.7M-233.3M-191.9M00
Financing Activities
Share Repurchases i--000
Dividends Paid i-----
Debt Issuance i-143.3M322.7M00
Debt Repayment i----0
Financing Cash Flow i329.7M184.8M322.7M00
Free Cash Flow i-44.2M-170.2M-322.5M-7.8M-3.1M
Net Change in Cash i258.9M-7.5M588.0K5.1M5.9M

Cash Flow Trend

Arunjyoti Bio Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 55.46
Price to Book 3.30
Price to Sales 4.16

Profitability Ratios

Profit Margin -4.34%
Operating Margin 31.87%
Return on Equity -5.63%
Return on Assets -3.06%

Financial Health

Current Ratio 2.80
Debt to Equity 80.95
Beta -0.49

Per Share Data

EPS (TTM) ₹-0.10
Book Value per Share ₹1.79
Revenue per Share ₹1.40

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
abvl1.1B55.463.30-5.63%-4.34%80.95
BLS International 163.3B28.909.4425.17%23.43%17.79
CMS Info Systems 73.1B19.773.2216.43%15.30%8.36
PDS 45.6B30.122.769.14%1.16%71.79
Intelligent Supply 36.6B272.73--3.90%99.63%1.04
Hinduja Global 25.0B60.390.321.55%-0.61%24.74

Financial data is updated regularly. All figures are in the company's reporting currency.